Sex differences in incidence of self-reported adverse drug reactions after percutaneous coronary intervention
During this year's European Society of Cardiology congress, Trond Røed Pettersen participated in the Nursing and Allied Professions Investigator Award Session in competition with researchers from Japan and Germany. Here, Røed Pettersen won a prize for his lecture on sex differences in the occurrence of self-reported adverse drug reactions (ADRs).
This year's European Society of Cardiology congress took place on 25-28 August in Amsterdam. The PROCARD research group was well represented during the congress. Members from the group were invited to hold lectures, present moderated ePosters and have chair assignments.
Trond Røed Pettersen presented his abstract "Sex differences in incidence of self-reported adverse drug reactions after percutaneous coronary interventions" in the Nursing and Allied Professions Investigator Award session. For this session, three finalists were selected to present their research in an oral presentation for two judges and the audience, with subsequent questions from the judges.
In the CONCARDPCI study, we found that more than 40% of the patients reported having experienced ADRs from the prescribed therapy at all three measuring time points. Furthermore, women reported significantly more ADRs from all 17 pre-defined organ systems, with the exception of the genitals, compared to men. Women were also significantly more likely to experience ADRs that led to contact with the healthcare system, including pharmacies, general practitioners, emergency departments and hospitals, compared to men. Nevertheless, women were less likely to receive information about potential ADRs from prescribed therapy than men.
After a brilliant lecture, Trond was named the winner of the ESC Nursing and Allied Professions Investigator Award 2023.